Categories
Company News

First Fertility Acquires the Fertility Institute of New Orleans

News and Insights

Index

First Fertility Acquires the Fertility Institute of New Orleans

Grows access to care in Louisiana as part of nationwide expansion plan

Avon, CT – December 20, 2021 – First Fertility, a nationwide fertility company focused on patient experience, announced that it has acquired The Fertility Institute of New Orleans, the first fertility clinic in the state. This acquisition will accelerate growth in Louisiana, creating more access to care for patients seeking infertility treatment in the Southern United States.

“As a fast growing fertility company, First Fertility is committed to smart growth that focuses on providing exceptional care to patients across the country,” said Derek Larkin, CEO of First Fertility. “Our investment in The Fertility Institute of New Orleans is a perfect example of that commitment to our patients, and we’re thrilled to bring the First experience to Louisiana.”

With locations in New Orleans (Metairie), Baton Rouge, and Mandeville, The Fertility Institute of New Orleans brings a wealth of experience to the First Fertility family of centers. Founded in 1976, their history as Louisiana’s first fertility clinic aligns with First Fertility’s mission to innovate with industry-leading and compassionate care that empowers patients and equalizes the ability for everyone to grow their family in the way they want. 

Dr. Peter Lu, of The Fertility Institute of New Orleans said, “We have worked for over forty years to build a fertility clinic that helps so many Louisianans overcome their struggles with infertility. As part of First Fertility, we look forward to continuing our tradition of care while bringing new and exciting programs to help everyone realize their dream of becoming a parent.”

About First Fertility

First Fertility offers comprehensive and customized care for patients to grow their families. The business partners with reproductive endocrinology practices across the United States, investing in and offering strategic opportunities to these Centers of Excellence so that physicians can focus on what matters most: taking care of their patients. Learn more at firstfertility.com.

Share This Post

We're Ready to Listen

Categories
Sverica News

Sverica Capital Management Announces Investment in ShadowDragon

News

Index

Sverica Capital Management Announces Investment in ShadowDragon

San Francisco, California – December 9, 2021 – Sverica Capital Management LP (“Sverica”), a private equity investment firm, announced today that it has made a strategic investment in ShadowDragon (“ShadowDragon” or the “Company”).

Founded in 2015, ShadowDragon is a leading threat intelligence software provider focused on offering open-source intelligence (OSINT) data and tools to both public sector and commercial clients to help streamline investigations and safeguard assets. The Company’s flagship product, SocialNet, helps aggregate data from 140+ different platforms across the clear, deep, and dark web to uncover identities, networks, and connections of potential threat actors. The Company offers a number of additional products including OIMonitor, MalNet, and Spotter that serve as useful tools to security teams across a wide array of use cases.

“I founded ShadowDragon with the mission of providing the good guys with the right tools to fight the bad guys… and win,” said Daniel Clemens, Founder and CEO of ShadowDragon. “We have made great strides in making tools to augment the capability of the good guys and level the playing field against complex adversaries. By combining our exceptional team, market need, and technology with the expertise and resources of Sverica, ShadowDragon has the opportunity to grow faster and accelerate innovation to help customers proactively respond to even the most advanced threats. We couldn’t be more excited to partner with the Sverica team and take ShadowDragon to the next level.” Clemens will continue to lead the Company, while Frank Young, Managing Partner at Sverica, and Michael Dougherty, Vice President at Sverica, will join ShadowDragon’s Board of Directors as part of the transaction.

“ShadowDragon has built an exceptional business by simply creating products that customers love. The Company has maintained tremendous growth without a formal sales effort, demonstrating the value customers receive and the opportunity to increase the awareness and reach of their differentiated products. We are thrilled to partner with Daniel and the team, as we look to further invest in the business to drive the next phase of growth,” said Frank Young, Managing Partner at Sverica.

Michael Dougherty, Vice President at Sverica, added “Organizations are continuing to evolve the sophistication of their security programs, including becoming more proactive instead of reactive, which requires building effective intelligence capabilities. Given that OSINT is a critical piece of any intelligence program, we believe ShadowDragon is well-positioned to benefit from positive tailwinds in the security space and are excited about the partnership with the team.”

About ShadowDragon

ShadowDragon provides publicly accessible information (PAI) and open-source intelligence (OSINT) software, data, and training to enable customers to prevent and attribute actions of threat actors in both the physical and digital world. ShadowDragon’s solutions are used by hundreds of businesses, as well as intelligence and law enforcement organizations around the world. The Company is based in the United States. For more information, visit shadowdragon.io.

Share This Post

We're Ready to Listen

Categories
Company News

Gener8 Has Acquired RND, Expanding Into Life Sciences Software Development

News and Insights

Index

Gener8 Has Acquired RND, Expanding Into Life Sciences Software Development

Sunnyvale, CA – December 7, 2021 – Gener8 LLC (“Gener8”), a portfolio company of Sverica Capital Management LP (“Sverica”), announced today that it has completed its acquisition of the RND Group (“RND”), a leading provider of software development focused on medical device and life science products, based in Indianapolis, Indiana.

With the acquisition of RND, Gener8 is adding full lifecycle software development capabilities, including cloud solutions, verification & validation, quality system compliance, LIS/EHR integration and more. The company has assembled a library of protocols that serve to accelerate the development process by leveraging pre-built core functionality. While Gener8 already provides turnkey instrument and consumable solutions, as well as accompanying firmware, the acquisition of RND enables Gener8 to extend its services off-instrument to the related software.

“RND is a world-class medical software development operation with a blue-chip customer base and a unique set of capabilities,” said Jerry Jurkiewicz, Gener8 CEO. “We have already partnered on several programs, and the value proposition of the combination has strongly resonated with customers.”

“We are excited to join Jerry and the rest of the Gener8 team. From our early interactions it was clear there would be a great fit between our companies, and even more importantly, that bringing our capabilities together under one roof would be a real winner for customers,” added Tim DeFrench, Founder and President of RND.

About Gener8

Gener8, founded in 2002, is a leading provider of turnkey design and manufacturing services specializing in high complexity products, primarily for medical device and diagnostics applications. Gener8 maintains state-of-the-art facilities and a world-class engineering team with more than 40 PhDs spanning a multitude of disciplines, including electrical, mechanical, software, optical and systems engineering. For more information, please visit www.gener8.net. 

Share This Post

We're Ready to Listen

Categories
Company News

Synoptek Announces Expansion with Acquisition of Rapid Technologies

News and Insights

Index

Synoptek Announces Expansion with Acquisition of Rapid Technologies

Irvine, CA – December 6, 2021 – Synoptek, leader in the global IT consulting field, today announced the strategic acquisition of Rapid Technologies, an Elite ServiceNow partner focused on consulting, implementation and managed services for ServiceNow’s industry-leading enterprise service management (ESM) solutions. The deal strengthens Synoptek’s ability to not only envision and implement ServiceNow solutions for its customers, but also to provide ongoing application support management offerings that will enable clients to get the most out of their investments.

Synoptek’s long and successful history of client partnerships within the ServiceNow ecosystem, paired with Rapid Technologies’ strong reputation for delivering ESM solutions, will reinforce Synoptek’s position as a leader in digital consulting, implementation and IT management. The relationship will also enhance business results through the two brands’ combined ServiceNow expertise.

“In today’s business climate, leaders are being extremely methodical when determining which computing strategies will push their organization to the next level, which has made ServiceNow a key platform to help support technology management,” said chief executive officer of Synoptek, Tim Britt. “As businesses form more and more reliance on their organizational technologies, they must demonstrate efficient operations and a sound return on the investment. ServiceNow is a critical tool for doing just that, and this acquisition gives us access to more expertise around a platform that has become so vital to our clientele. As we continue to build up our resources to support customer needs, acquiring Rapid Technologies was both a strategic decision and seamless fit.”

As a trusted ServiceNow partner, Rapid Technologies brings a level of expertise that Synoptek is poised to leverage and immediately incorporate into the company’s current service offerings. “This move truly allows Synoptek to further commit to a deeper global ServiceNow integration, while also utilizing Rapid Technologies’ like-minded focus on quality service and exceptional results,” added Britt.

Rapid Technologies has been delivering exemplary consulting and implementation services for successful ESM project deployment for over two decades. Providing superior expertise across industry verticals, the organization has seen ample growth as the demand for ServiceNow best practice guidance and ongoing support has increased. As part of the acquisition, Rapid Technologies chief executive officer and president, Bill Mell, along with current vice president of professional services, Charley Whitt, will serve as managing directors of the ServiceNow practice within Synoptek.

“The decision to merge with Synoptek provides extended service and solution offerings for our clients, as well as a major growth opportunity for both of our businesses,” said Mell. “As we leverage our combined team’s deep bench of expertise, we’re eager to continue our commitment to delivering innovative ServiceNow solutions to customers while making an impact in the communities that we serve.”

Along with its current IT leadership, consulting and managed service offerings, Synoptek will extend its ServiceNow arm with the addition of:

  • Co-managed ServiceNow capabilities
  • ServiceNow application managed services
  • ServiceNow implementation and project expertise across the Now Platform®

“Above all, both parties are fully committed to accelerating client business outcomes through our collective value-added offerings. Our customers depend on flawless and persistent IT leadership and management of their systems, and the union of our industry-leading organizations will be key in executing that commitment,” concluded Britt.

About Synoptek

Synoptek is a business and technology consulting firm that helps companies envision, transform and evolve. As a global systems integrator and managed technology services provider, Synoptek partners with organizations worldwide to help them navigate the ever-changing technology landscape and build solid foundations for their business. With its comprehensive offerings, global workforce and strategic technology partnerships, Synoptek helps organizations grow their business while optimizing and protecting their ecosystem. With growth, ownership, inclusivity and philanthropy embedded in its DNA, Synoptek is committed to delivering improved business results and unmatched service to all its stakeholders. Discover more at www.synoptek.com, or connect with Synoptek on Facebook, Twitter and LinkedIn.

About Rapid Technologies

Rapid Technologies, an Elite ServiceNow partner, provides consulting, implementation and support services with a focus on giving back to the community through its ServiceNow for Good program.

Share This Post

We're Ready to Listen

Categories
Sverica News

Sverica Capital Management Announces Strategic Investment in Resonetics by Carlyle

News

Index

Sverica Capital Management Announces Strategic Investment in Resonetics by Carlyle

Investment to Support Continued Growth and Expansion of Specialized Medical Device Contract Manufacturer

Nashua, NH & Boston – Sverica Capital Management LP (“Sverica”) announced today that its portfolio company, Resonetics (or the “Company”), has sold a minority equity stake to funds affiliated with global investment firm Carlyle (NASDAQ: CG), valuing the Company at approximately $2.25 billion. Sverica initially acquired Resonetics in 2014, and then sold a majority interest in the Company in 2018 to private equity firm GTCR. Carlyle will join GTCR as a meaningful shareholder in Resonetics, and Sverica will retain a minority position as a result of the transaction.

Founded in 1987 and headquartered in Nashua, NH, Resonetics is a leader in micro-manufacturing for medical devices, targeting fast-growing interventional and minimally-invasive applications across the MedTech industry. The Company is focused on fabricating highly technical componentry for complex medical device applications, serving end-markets that are experiencing robust growth as clinicians shift away from higher-risk, invasive procedures, towards more interventional approaches. Resonetics has established itself as a mission-critical supplier enabling innovations in several high growth MedTech end-markets including diabetes, neurovascular, ophthalmology, interventional cardiology, and structural heart, among others.

Sverica made its initial investment in Resonetics in October 2014, taking a majority position in what was then a single-location Company focused on polymer componentry serving medical device programs. Under Sverica’s ownership, Resonetics grew to six locations and expanded its capabilities into laser-machining metal components through a combination of de novo and acquisitive growth under the leadership of CEO Tom Burns. Sverica partnered with GTCR and medical device industry executive Chip Hance, who became Executive Chairman of Resonetics, in February 2018 to continue pursuing opportunities in the medical device sector, significantly growing the Company’s revenue and EBITDA over the ensuing four years through strong organic growth and eight strategic add-on acquisitions.

Dave Finley, Managing Partner at Sverica, said, “Resonetics has been a successful growth story for Sverica’s business-builder private equity model within our Advanced Industrial vertical. The opportunity to extend the relationship with Tom Burns, Chip Hance and the Resonetics team over the last four years, and build a new partnership with GTCR has been fantastic. We look forward to continuing to retain a minority position under joint leadership of the Company by GTCR and Carlyle.”

About Sverica Capital Management

Sverica Capital Management is a leading growth oriented private equity firm that has raised over $1.1 billion across five funds. The firm acquires, invests in and actively builds companies that are, or could become, leaders in their industries. Since inception, Sverica has followed a “business builder” approach to investing and takes an active supporting role in its portfolio companies. Sverica devotes significant internal time and resources to help its management teams develop and execute growth strategies and proactively looks for levers to pull to accelerate growth by reinvesting back into those companies. Sverica firmly believes in building businesses collaboratively that can endure for the long term by starting with a strong foundation and bringing the right people and playbook to drive reinvestment and ultimately strong returns for our investors.

For more information, please visit https://sverica.com.

About Resonetics

Founded in 1987, Resonetics is a pioneer in advanced engineering and manufacturing solutions for the life sciences industry. Resonetics is a leader in laser processing, centerless grinding, nitinol processing, thin-wall stainless steel and precious metal tubing, photochemical machining, metal fabrication, and fiber optic sensors. With nine Lightspeed Application Development Labs located strategically to serve medical device companies around the world, Resonetics is built on a foundation of quality, speed, and innovation to deliver best-in-class value with a customer-centric approach. The company is ISO 13485:2016 certified with facilities in the United States, Costa Rica, Israel, Switzerland, and Canada.

For more information, please visit https://resonetics.com/.

Share This Post

We're Ready to Listen